Avadel pharmaceuticals to join russell 3000® index

Dublin, june 27, 2024 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it is set to join the broad-market russell 3000® index at the conclusion of the 2024 russell us indexes annual reconstitution, effective at the open of us equity markets on monday, july 1, 2024, according to a preliminary list of additions posted friday, may 24, 2024.
AVDL Ratings Summary
AVDL Quant Ranking